HER-2 is an oncogene that is generally associated with malignant tumors such as breast cancer and gastric cancer.
1. HER-2 refers to human epidermal growth factor receptor-2, which is an oncogene that can regulate cell growth and proliferation, and has tumor transforming activity. HER-2 is expressed at a higher level in the fetus, but at a lower level in adults.
2. It is mainly used to determine the actual prognosis of cancer patients, and cancer patients need to refer to this index when choosing drug treatment. when HER-2 is positive, targeted drugs can be used for treatment under the guidance of professional doctors.
If HER-2 is positive, targeted drug therapy should be given under the guidance of doctors.